| Literature DB >> 35502235 |
Jing Zhang1, Fang Wang1, Satya Siva Kishan Yalamarty2, Nina Filipczak2, Yi Jin1, Xiang Li1.
Abstract
Nano silver is one of the most widely used engineering nanomaterials with antimicrobial activity against bacteria, fungi, and viruses. However, the widespread application of nano silver preparations in daily life raises concerns about public health. Although several review articles have described the toxicity of nano silver to specific major organs, an updated comprehensive review that clearly and systematically outlines the harmful effects of nano silver is lacking. This review begins with the routes of exposure to nano silver and its distribution in vivo. The toxic reactions are then discussed on three levels, from the organ to the cellular and subcellular levels. This review also provides new insights on adjusting the toxicity of nano silver by changing their size and surface functionalization and their combination with other materials to form a composite formulation. Finally, future development, challenges, and research directions are discussed.Entities:
Keywords: distribution; exposure routes; mechanism; nano silver; toxicity
Mesh:
Year: 2022 PMID: 35502235 PMCID: PMC9056105 DOI: 10.2147/IJN.S355131
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1Various routes of exposure to nano silver in human body.
Toxicity of Nano Silver in Different Organs
| Animals | Dose | End-Point | Toxic Effect | Related Organs | Mechanism | Ref. |
|---|---|---|---|---|---|---|
| Healthy adult male mice | 2 mg·kg−1 | 35 days | Alterations in the ultrastructure of the liver; focal hepatocytes necrosis and apoptosis | Liver | Free radical production and oxidative stress induction | [ |
| Healthy female New Zealand rabbits | 0.1 g·kg−1 | 24 and 72 h | Ultrastructural pathological changes and the promoted cytotoxic reactions | Generative organ | - | [ |
| Zebrafish | 8, 45, and 70 µg·L−1 | 30 days | Reversible damage to the mucosal epithelium of the gills, and to a lesser degree to the intestinal tissue | Gut, liver and gills | - | [ |
| Drosophila melanogaster | 50 mg·L−1 | 10, 20, and 30 days | Behavioral abnormalities and altered metabolic activity at early larval stage | Fat body and wing imaginal disc | Impaired essential metabolic components, and increased reactive oxygen species | [ |
Toxicity of Nano Silver in Different Cells
| Cells | Dose (μg·mL−1) | End-Point | Toxic Effect | Ref. |
|---|---|---|---|---|
| NCM460 | 3–60 | 24 h | Increased intracellular ROS content | [ |
| HCT116 | ||||
| A549 cells | 0.5–5 | Oxidative damage | [ | |
| Cardiomyocytes | 0.001–1 | 1 h | Rapid collapses of TMP and loss of excitability | [ |
| Human embryonic stem cells | 0.001–0.1 | 18 days | Changes in endoderm-derived hepatocyte differentiation | [ |
| NTERA-2 | 10–100 | 24, 48, and 72 h | Cytotoxicity and cell inhibition, DNA damage | [ |
| Primary testicular cells |
Figure 2Mechanisms of entry of silver nanoparticles into the organism and potential mechanisms of nano silver-induced cytotoxicity in the cell.
The Influence of Size Distribution of Silver Nanoparticles on Their Toxicity
| Cells | Size (nm) | Time | Toxic Effect | Ref. |
|---|---|---|---|---|
| Kupffer cells | 10 | 35 days | Destruction and reduction of ER, mitochondrial swelling, and cytoplasmic vacuolation | [ |
| Mucosa epithelial cells | 20–40 | 24 and 72 h | Loose and detached | [ |
| 50 | 30 days | Sub-epithelial edema, hyperplasia, lamellar fusion, and the reduction of the length of intestinal villi | [ | |
| Neuronal cells | 20, 70 | 7 days, 24 h | Inhibition in dopamine efflux in both mature and developing neurons | [ |
| 10, 50 | 12 h | Production of ROS | [ |